HealthCor Management’s Bristol-Myers Squibb BMY Stock Holding History

HealthCor Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-223,150	Closed	-$15.9M	–	31
2022 Q3	$15.9M	Sell	223,150 -189,270	-46%	-$13.7M	1.98%	22
2022 Q2	$31.8M	Sell	412,420 -117,740	-22%	-$8.97M	3.19%	8
2022 Q1	$38.7M	Sell	530,160 -1,274,390	-71%	-$85.6M	2.58%	17
2021 Q4	$113M	Sell	1,804,550 -1,779,610	-50%	-$104M	6.12%	2
2021 Q3	$212M	Buy	3,584,160 +2,109,790	+143%	+$139M	9.15%	1
2021 Q2	$98.5M	Buy	+1,474,370	New	+$96.1M	3.94%	9
2021 Q1	–	Sell	-1,297,700	Closed	-$80.5M	–	86
2020 Q4	$80.5M	Buy	1,297,700 +1,172,200	+934%	+$72.1M	3.1%	13
2020 Q3	$7.57M	Sell	125,500 -937,000	-88%	-$56.4M	0.3%	32
2020 Q2	$62.5M	Buy	1,062,500 +888,140	+509%	+$53.1M	2.62%	16
2020 Q1	$9.72M	Sell	174,360 -665,640	-79%	-$40.7M	0.42%	43
2019 Q4	$53.9M	Sell	840,000 -277,710	-25%	-$15.9M	1.92%	21
2019 Q3	$56.7M	Sell	1,117,710 -894,940	-44%	-$42.1M	2.14%	19
2019 Q2	$91.3M	Buy	+2,012,650	New	+$93.7M	3.54%	10
2019 Q1	–	Sell	-294,490	Closed	-$15.3M	–	53
2018 Q4	$15.3M	Buy	+294,490	New	+$15.8M	0.48%	36
2018 Q3	–	Sell	-488,750	Closed	-$27M	–	46
2018 Q2	$27M	Sell	488,750 -112,330	-19%	-$6.07M	0.86%	35
2018 Q1	$38M	Buy	601,080 +196,410	+49%	+$12.6M	1.29%	26
2017 Q4	$24.8M	Buy	404,670 +113,530	+39%	+$7.1M	0.81%	30
2017 Q3	$18.6M	Sell	291,140 -523,980	-64%	-$30.6M	0.62%	36
2017 Q2	$45.4M	Buy	815,120 +365,120	+81%	+$19.9M	1.64%	21
2017 Q1	$24.5M	Buy	+450,000	New	+$24.7M	1.12%	25
2016 Q3	–	Sell	-211,940	Closed	-$15.6M	–	39
2016 Q2	$15.6M	Sell	211,940 -99,770	-32%	-$7.05M	0.85%	33
2016 Q1	$19.9M	Buy	+311,710	New	+$19.7M	1.13%	27

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

HealthCor Management's BMY Position: Q4 2022 in Review

HealthCor Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 223,150 shares — an estimated $15.9M sold.

HealthCor Management first reported a position in BMY in Q1 2016 and held it in 22 quarters. The position peaked at $212M in Q3 2021. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

HealthCor Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 223,150 Bristol-Myers Squibb shares in Q4 2022, an estimated $15.9M.
HealthCor Management first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 22 quarters.
HealthCor Management's Bristol-Myers Squibb position peaked at $212M in Q3 2021.
2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.